Cross AL، Viswanath O، Sherman AI (19 يوليو 2022). "Pregabalin". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID:29261857. مؤرشف من الأصل في 2022-08-03. اطلع عليه بتاريخ 2022-08-27 – عبر NCBI Bookshelf.
Cross AL، Viswanath O، Sherman AI (19 يوليو 2022). "Pregabalin". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID:29261857. مؤرشف من الأصل في 2022-08-03. اطلع عليه بتاريخ 2022-08-27 – عبر NCBI Bookshelf.
Drug Enforcement Administration, Department of Justice (July 2005). "Schedules of controlled substances: placement of pregabalin into schedule V. Final rule". Federal register 70 (144): 43633–5. ببمد: 16050051. Retrieved 2012-01-22.
Attal N, Cruccu G, Baron R et al. (September 2010). "EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision". Eur. J. Neurol. 17 (9): 1113–e88. doi:10.1111/j.1468-1331.2010.02999.x. ببمد: 20402746.
Finnerup, NB; Sindrup SH; Jensen TS (September 2010). "The evidence for pharmacological treatment of neuropathic pain". Pain 150 (3): 573–81.doi:10.1016/j.pain.2010.06.019. ببمد: 20705215.
Bennett, M.I. (November 2013). "Pregabalin for acute and chronic pain in adults.".Pain Med 14 (11): 1681–8. doi:10.1111/pme.12212. ببمد: 23915361.
Linde, M; Mulleners, WM; Chronicle, EP; McCrory, DC (Jun 24, 2013). "Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults.". The Cochrane database of systematic reviews 6: CD010609. doi:10.1002/14651858.CD010609. ببمد: 23797675.
Chaparro LE, Smith SA, Moore RA, Wiffen PJ, Gilron I (2013). "Pharmacotherapy for the prevention of chronic pain after surgery in adults". Cochrane Database Syst Rev 7: CD008307. doi:10.1002/14651858.CD008307.pub2. ببمد: 23881791.
Moore, RA; Straube, S; Wiffen, PJ; Derry, S; McQuay, HJ (Jul 8, 2009). "Pregabalin for acute and chronic pain in adults.". The Cochrane database of systematic reviews (3): CD007076. doi:10.1002/14651858.CD007076.pub2. ببمد: 19588419.
Wensel TM, Powe KW, Cates ME (March 2012). "Pregabalin for the treatment of generalized anxiety disorder". Ann Pharmacother 46 (3): 424–9. doi:10.1345/aph.1Q405.ببمد: 22395254.
Owen, Richard T. (September 2007). "Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety". Drugs of Today 43 (9): 601–10.doi:10.1358/dot.2007.43.9.1133188. ببمد: 17940637. Retrieved 2012-01-22.
Bandelow B, Sher L, Bunevicius R et al. (June 2012). "Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care". Int J Psychiatry ClinPract 16 (2): 77–84.doi:10.3109/13651501.2012.667114. ببمد: 22540422.
Hindmarch I. et al. (Feb 2005). "A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo.". Sleep 28 (2): 187–93. ببمد: 16171242.
Bandelow, B.; Wedekind, D.; Leon, T. (Jul 2007). "Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention". Expert Rev Neurother 7(7): 769–81. doi:10.1586/14737175.7.7.769. ببمد: 17610384.
Owen, RT. (Sep 2007). "Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety". Drugs Today (Barc) 43 (9): 601–10.doi:10.1358/dot.2007.43.9.1133188. ببمد: 17940637
Yoo, Lawrence; Matalon, Daniel; Hoffman, Robert S.; Goldfarb, David S. (2009). "Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure". American Journal of Kidney Diseases 54 (6): 1127–30. doi:10.1053/j.ajkd.2009.04.014.ببمد: 19493601.
Micheva KD, Taylor CP, Smith SJ (April 2006). "Pregabalin Reduces the Release of Synaptic Vesicles from Cultured Hippocampal Neurons" (PDF). Molecular Pharmacology70 (2): 467–476. doi:10.1124/mol.106.023309. ببمد: 16641316.
Strawn, JR; Geracioti Jr, TD (2007). "The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic". Neuropsychiatric disease and treatment 3 (2): 237–43. doi:10.2147/nedt.2007.3.2.237. PMC 2654629. ببمد: 19300556.
Dworkin, Robert H.; Kirkpatrick, Peter (June 2005). "Pregabalin" (PDF). Nature Reviews Drug Discovery 4 (6): 455–456. doi:10.1038/nrd1756. ببمد: 15959952. Retrieved 2012-01-22.
Bandelow, Borwin; Wedekind, Dirk; Leon, Teresa (July 2007). "Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention". Expert Review of Neurotherapeutics 7 (7): 769–781. doi:10.1586/14737175.7.7.769.ببمد: 17610384. Retrieved 2011-11-06
Chalabianloo, F; Schjøtt J (January 2009). "Pregabalin and its potential for abuse".Journal of the Norwegian Medical Association 129 (3): 186–187.doi:10.4045/tidsskr.08.0047. ببمد: 19180163.
pubmed.ncbi.nlm.nih.gov
Cross AL، Viswanath O، Sherman AI (19 يوليو 2022). "Pregabalin". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID:29261857. مؤرشف من الأصل في 2022-08-03. اطلع عليه بتاريخ 2022-08-27 – عبر NCBI Bookshelf.
Cross AL، Viswanath O، Sherman AI (19 يوليو 2022). "Pregabalin". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID:29261857. مؤرشف من الأصل في 2022-08-03. اطلع عليه بتاريخ 2022-08-27 – عبر NCBI Bookshelf.
web.archive.org
Expert Committee on Drug Dependence Forty-first Meeting (نوفمبر 2018). Critical Review Report: Pregabalin(PDF) (Report). Geneva: World Health Organization. مؤرشف من الأصل(PDF) في 2020-10-26.
Cross AL، Viswanath O، Sherman AI (19 يوليو 2022). "Pregabalin". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID:29261857. مؤرشف من الأصل في 2022-08-03. اطلع عليه بتاريخ 2022-08-27 – عبر NCBI Bookshelf.
Cross AL، Viswanath O، Sherman AI (19 يوليو 2022). "Pregabalin". StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID:29261857. مؤرشف من الأصل في 2022-08-03. اطلع عليه بتاريخ 2022-08-27 – عبر NCBI Bookshelf.
Expert Committee on Drug Dependence Forty-first Meeting (نوفمبر 2018). Critical Review Report: Pregabalin(PDF) (Report). Geneva: World Health Organization. مؤرشف من الأصل(PDF) في 2020-10-26.
